Global Journal of Medical Pharmaceutical and Biomedical Update

Scope & Guideline

Bridging Gaps in Pharmaceutical and Biomedical Research

Introduction

Delve into the academic richness of Global Journal of Medical Pharmaceutical and Biomedical Update with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherSCIENTIFIC SCHOLAR LLC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationGLOB J MED PHARM BIO / Glob. J. Med. Pharm. Biomed. Update
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address50, WOODGREEN DR, PITTSFORD, NY 14534

Aims and Scopes

The Global Journal of Medical Pharmaceutical and Biomedical Update focuses on a diverse range of topics within the medical and pharmaceutical fields, emphasizing research that impacts clinical practice and healthcare outcomes. The journal is dedicated to disseminating innovative findings and methodologies that contribute to advancements in biomedical sciences.
  1. Clinical Research and Trials:
    The journal frequently publishes studies related to clinical trials, systematic reviews, and randomized controlled trials, which provide evidence for effective treatments and therapies in various medical conditions.
  2. Pharmaceutical Sciences:
    Research on drug development, efficacy, and safety, including the exploration of new drug therapies and their impacts on patient outcomes, is a core focus area.
  3. Public Health and Epidemiology:
    The journal covers studies that examine public health issues, disease prevalence, and the impact of social determinants on health, highlighting the importance of addressing community health challenges.
  4. Innovative Therapeutic Approaches:
    There is a consistent emphasis on novel treatment methodologies, including herbal medicine, dietary supplements, and alternative therapies, reflecting a growing interest in integrative medicine.
  5. Technological Advancements in Medicine:
    The integration of technology, particularly artificial intelligence and novel diagnostic methods, is an important aspect of the research published, indicating a trend toward modernizing medical practices.
  6. Mental Health Research:
    The journal addresses mental health issues, including the psychological impacts of diseases and stressors, emphasizing the need for holistic treatment approaches.
The Global Journal of Medical Pharmaceutical and Biomedical Update has demonstrated responsiveness to current health trends and emerging fields of study, as evidenced by its recent publications. This reflects an adaptive approach to addressing contemporary healthcare challenges.
  1. Impact of COVID-19:
    Research focusing on COVID-19, including its long-term effects, associated mental health issues, and implications for public health, has surged, highlighting the pandemic's significant influence on ongoing medical research.
  2. Artificial Intelligence in Healthcare:
    The application of artificial intelligence in various medical fields, particularly in diagnostics and treatment planning, is emerging as a significant theme, suggesting a shift towards data-driven healthcare solutions.
  3. Chronic Disease Management:
    Increasing attention is being directed towards managing chronic diseases such as diabetes and kidney disease, reflecting a growing recognition of the importance of long-term patient care and lifestyle interventions.
  4. Mental Health and Well-being:
    There is a rising trend in research addressing mental health, particularly in relation to stress, anxiety, and depression, which is increasingly recognized as a critical component of overall health.
  5. Antimicrobial Resistance:
    Research on antimicrobial resistance has gained momentum, indicating a heightened awareness of this global health crisis and the need for innovative solutions to combat resistant pathogens.

Declining or Waning

While the journal has maintained a strong focus on emerging medical and pharmaceutical topics, certain themes have shown a decline in prominence over recent years. This may reflect shifts in research priorities or evolving healthcare challenges.
  1. Traditional Medicine:
    Research related to traditional or alternative medicine practices appears to be decreasing, possibly as the focus shifts toward more evidence-based and technologically driven approaches.
  2. Aging and Geriatric Health:
    Topics specifically addressing aging populations, geriatric care, and associated health issues have become less frequent, which may indicate a need for renewed interest in this demographic's healthcare.
  3. Invasive Medical Procedures:
    There has been a noticeable reduction in studies focusing on invasive surgical techniques, as the journal seems to be prioritizing less invasive or alternative treatment options.

Similar Journals

Journal of Research in Pharmacy Practice

Connecting researchers and practitioners for enhanced patient care.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2319-9644Frequency: 4 issues/year

Journal of Research in Pharmacy Practice, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, is a premier open-access journal dedicated to advancing the field of pharmaceutical sciences through rigorous research and innovative practices. Since its inception, the journal has aimed to bridge gaps between pharmacy practice and research, providing a platform for researchers, professionals, and students alike to disseminate their findings and insights. With a commitment to high-quality, peer-reviewed content, the journal covers a wide array of topics including clinical pharmacy, medication management, and healthcare policies, contributing to the enhancement of global healthcare practices. The journal is easily accessible online, having embraced an open-access model since 2012, ensuring that valuable research is freely available to all. Engaging with the Journal of Research in Pharmacy Practice not only facilitates knowledge exchange but also aids in the continuous evolution of pharmacy practice, emphasizing its critical role in healthcare delivery and patient outcomes.

Journal of the Chinese Medical Association

Fostering Excellence in Asian Medical Discourse
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1726-4901Frequency: 12 issues/year

Journal of the Chinese Medical Association, published by LIPPINCOTT WILLIAMS & WILKINS, is a prominent peer-reviewed journal in the field of general medicine, specifically focused on advancements and research within the Chinese medical community. Established in 2003 and with a scope that spans diverse medical disciplines, this journal has positioned itself as a key resource for medical professionals, researchers, and academics interested in both clinical practices and health policy in Taiwan and the broader context of Asian medicine. With an impressive Scopus ranking of 69 out of 636 in the general medicine category and a notable percentile rank of 89th, the journal is recognized for its contributions to medical science. Although it does not currently provide open access options, it continues to maintain a robust presence through its high-quality publications and rigorous peer-review process aimed at fostering innovation and sharing critical insights across the medical field. Researchers and students alike will find this journal an invaluable platform for disseminating their findings and engaging with current medical discourse.

Research in Pharmaceutical Sciences

Driving Collaboration in Pharmaceutical Sciences
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1735-5362Frequency: 6 issues/year

Research in Pharmaceutical Sciences is a premier, peer-reviewed journal published by Wolters Kluwer Medknow Publications, dedicated to advancing the field of pharmacology, toxicology, and pharmaceutics. With an impact factor that positions it in the second quartile of its category (Q2) and a respectable rank of 23 out of 80 in Scopus, this journal serves as an essential platform for researchers, professionals, and students alike, providing open access since 2015 to a wealth of pioneering studies and comprehensive reviews. Based in Mumbai, India, the journal encompasses a diverse range of topics within the pharmaceutical sciences, offering insights that address both theoretical and practical challenges in drug development and safety. As it converges from 2009 to 2024, Research in Pharmaceutical Sciences continues to be a vital source of knowledge, promoting innovation and fostering collaboration within the global scientific community.

Biomedical Reports

Exploring the frontiers of biochemistry and genetics.
Publisher: SPANDIDOS PUBL LTDISSN: 2049-9434Frequency: 6 issues/year

Biomedical Reports, published by SPANDIDOS PUBL LTD in Greece, is a distinguished open-access journal that focuses on the dynamic fields of biochemistry, genetics, molecular biology, medicine, pharmacology, and neuroscience. Established in 2014, the journal has rapidly gained recognition, securing Q2 and Q3 rankings in several categories for 2023, including a notable ranking of #125/636 in General Medicine, placing it in the 80th percentile amongst its peers. The journal continually aims to disseminate innovative research findings that advance the understanding of complex biomedical issues, making it an invaluable resource for researchers, professionals, and students alike. Its multidisciplinary approach not only reflects the interconnectivity of modern biomedical sciences but also promotes collaborative discourse among diverse fields, ensuring ongoing relevance and impact within the scientific community.

Malaysian Journal of Medical Sciences

Advancing medical knowledge for a healthier tomorrow.
Publisher: PENERBIT UNIV SAINS MALAYSIAISSN: 1394-195XFrequency: 6 issues/year

Malaysian Journal of Medical Sciences, published by PENERBIT UNIVERSITI SAINS MALAYSIA, is a distinguished open-access journal dedicated to advancing knowledge in the field of medicine. With an E-ISSN of 2180-4303 and a comprehensive publication history dating back to 2003, the journal has carved out a notable presence in the academic community, achieving a Scopus rank of #198 in the General Medicine category and placing in the 68th percentile for its contributions. The journal, classified in the Q3 quartile for the year 2023, encompasses a broad spectrum of medical disciplines, providing a platform for researchers and professionals to share valuable insights and discoveries that can influence healthcare practices in Malaysia and beyond. As an open-access publication since 2017, it ensures that cutting-edge research is accessible to a wider audience, fostering collaboration and innovation in the medical sciences. Whether you are a seasoned researcher, a healthcare professional, or a dedicated student, the Malaysian Journal of Medical Sciences offers a vital resource to enhance your understanding of contemporary medical advancements.

Journal of Pharmacy and Bioallied Sciences

Connecting Researchers, Practitioners, and Students
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0976-4879Frequency: 6 issues/year

The Journal of Pharmacy and Bioallied Sciences is a premier open access publication that has been contributing to the fields of Pharmacy, Bioengineering, and Biochemistry since its establishment in India, under the esteemed Wolters Kluwer Medknow Publications. With the ISSN 0976-4879 and E-ISSN 0975-7406, this journal provides a platform for high-quality research articles, reviews, and clinical studies aimed at advancing knowledge and practice in the pharmaceutical and allied sciences. As a reflection of its academic stature, the journal holds a respectable categorization within the third and fourth quartiles in pertinent fields according to the latest metrics, with rankings that place it among prominent emerging research in pharmacology and biochemistry. Researchers and professionals are encouraged to access a wealth of knowledge freely, as the journal has been open access since 2010. The journal not only aims to foster innovative research but also strives to bridge the gap between pharmaceutical sciences and real-world applications, making it an essential resource for students, academics, and industry experts alike.

Galen Medical Journal

Bridging Research and Practice for Better Outcomes
Publisher: SALVIA MEDICAL SCIENCES LTDISSN: 2588-2767Frequency: 1 issue/year

Galen Medical Journal, established by SALVIA MEDICAL SCIENCES LTD, is a distinguished publication in the field of medicine, focusing on innovative research and developments that advance healthcare knowledge and practice. With a commitment to open access and the dissemination of critical medical findings, this journal serves as a vital resource for researchers, clinicians, and students alike. Based in London, England, at 40 Bloomsbury Way, London WC1A 2SE, the journal has been providing a platform for high-quality research since its inception. Though its coverage in Scopus has been discontinued, Galen Medical Journal continues to foster scholarly communication by publishing pioneering studies that contribute to the ongoing dialogue in the medical community. Researchers seeking to publish impactful findings are encouraged to consider this journal as an avenue for reaching a wide audience dedicated to improving patient care and healthcare outcomes.

Annals of Medicine and Surgery

Bridging Disciplines for Enhanced Patient Care
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2049-0801Frequency: 12 issues/year

Annals of Medicine and Surgery is a reputable multidisciplinary journal published by Lippincott Williams & Wilkins, focusing on a broad range of topics pertinent to both medicine and surgery. With an ISSN of 2049-0801, this journal aims to disseminate innovative research findings and clinical studies that contribute to the advancement of medical and surgical practices. Since its inception in 2012, it has established itself within the academic community, achieving a Q3 ranking in both the Medicine (miscellaneous) and Surgery categories for 2022. Despite its coverage being discontinued in Scopus, the journal continues to receive attention, ranked in the 45th percentile for its fields, illustrating its growing influence. Researchers, healthcare professionals, and students will find in this journal an invaluable resource for enhancing their understanding and staying updated with evolving medical and surgical landscapes. Access options are currently managed through institutional subscriptions, ensuring the dissemination of high-quality research to a diverse audience.

CHINESE MEDICAL JOURNAL

Advancing global health through innovative research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0366-6999Frequency: 24 issues/year

CHINESE MEDICAL JOURNAL, published by Lippincott Williams & Wilkins, is a distinguished platform within the field of medicine, providing a vital forum for the dissemination of innovative research and clinical findings since its inception in 1946. With its open access model established in 2000, the journal ensures that critical medical advancements and insights are accessible to a global audience, fostering collaboration and continuous learning among researchers, healthcare professionals, and students alike. The journal’s impressive Q1 ranking in Medicine (miscellaneous), alongside its remarkable Scopus rank of #40 out of 636 in General Medicine, underscores its influential presence in the medical community, promoting high-quality research that advances health outcomes. As it converges historical and contemporary research, the CHINESE MEDICAL JOURNAL plays an essential role in bridging academic inquiry with practical medical application, emphasizing its commitment to improving global healthcare through rigorous scholarship and excellence.

Journal of Reports in Pharmaceutical Sciences

Unveiling the Future of Biopharmaceutical Technologies.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2322-1232Frequency: 2 issues/year

Journal of Reports in Pharmaceutical Sciences is a pivotal publication in the realm of pharmaceutical research, disseminating innovative findings that cater to the evolving landscape of pharmacology, toxicology, and biomedical engineering. Published by Wolters Kluwer Medknow Publications, the journal serves as a bridge for scholars and practitioners aiming to enhance their understanding of drug development, therapeutic advances, and biopharmaceutical technologies. With an ISSN of 2322-1232 and E-ISSN 2322-5106, it has established its relevance from 2012 to 2022, occupying notable quartile rankings, including Q3 in Pharmacology, Toxicology, and Pharmaceutics. Despite being categorized in Q4 in some areas, the journal's commitment to quality research ensures it remains a respected platform for disseminating significant insights. Researchers, professionals, and students alike will find this journal an indispensable resource for staying updated on critical advancements in pharmaceutical sciences, making it a go-to source for impactful studies that shape industry practices and academic inquiries.